Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Knop

Showing results (261-270 of 509) with videos related to

Pageof 51
Sort By:
Lancet (London, England)|June 29, 2023
Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trialVanita R Aroda, Jens Aberle, Lars Bardtrum, et al.
Diabetes|October 2, 2020
The Role of Glucagon in the Acute Therapeutic Effects of SGLT2 InhibitionSofie Hædersdal, Asger Lund, Elisabeth Nielsen-Hannerup, et al.
Diabetes, Obesity & Metabolism|September 7, 2021
Glucose-dependent insulinotropic polypeptide induces lipolysis during stable basal insulin substitution and hyperglycaemia in men with type 1 diabetes: A randomized, double-blind, placebo-controlled, crossover clinical trialSebastian M N Heimburger, Chris N Nielsen, Salvatore Calanna, et al.
Frontiers in Endocrinology|April 30, 2024
Accuracy of continuous glucose monitoring during exercise-related hypoglycemia in individuals with type 1 diabetesKaisar Maytham, Per G Hagelqvist, Susanne Engberg, et al.
BJS Open|October 6, 2020
Alterations in blood microbiota after colonic cancer surgeryJ H Søby, S K Watt, R P Vogelsang, et al.
European Journal of Endocrinology|November 21, 2024
Response to "Advancing understanding of metabolic consequences of cholecystectomy: review reflection"Andreas H Lange, Miriam G Pedersen, Anne-Marie Ellegaard, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2003
The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotypeT Vilsbøll, F K Knop, T Krarup, et al.
Diabetes, Obesity & Metabolism|February 15, 2013
Reduced postprandial GLP-1 responses in women with gestational diabetes mellitusL Bonde, T Vilsbøll, T Nielsen, et al.
Diabetes, Obesity & Metabolism|February 12, 2017
Effect of exercise combined with glucagon-like peptide-1 receptor agonist treatment on cardiac function: A randomized double-blind placebo-controlled clinical trialPeter G Jørgensen, Magnus T Jensen, Pernille Mensberg, et al.
British Journal of Pharmacology|November 18, 2015
N-terminally and C-terminally truncated forms of glucose-dependent insulinotropic polypeptide are high-affinity competitive antagonists of the human GIP receptorL S Hansen, A H Sparre-Ulrich, M Christensen, et al.
Pageof 51

Showing results (261-270 of 509) with videos related to

Sort By:
Pageof 51
Lancet (London, England)|June 29, 2023
Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trialVanita R Aroda, Jens Aberle, Lars Bardtrum, et al.
Diabetes|October 2, 2020
The Role of Glucagon in the Acute Therapeutic Effects of SGLT2 InhibitionSofie Hædersdal, Asger Lund, Elisabeth Nielsen-Hannerup, et al.
Diabetes, Obesity & Metabolism|September 7, 2021
Glucose-dependent insulinotropic polypeptide induces lipolysis during stable basal insulin substitution and hyperglycaemia in men with type 1 diabetes: A randomized, double-blind, placebo-controlled, crossover clinical trialSebastian M N Heimburger, Chris N Nielsen, Salvatore Calanna, et al.
Frontiers in Endocrinology|April 30, 2024
Accuracy of continuous glucose monitoring during exercise-related hypoglycemia in individuals with type 1 diabetesKaisar Maytham, Per G Hagelqvist, Susanne Engberg, et al.
BJS Open|October 6, 2020
Alterations in blood microbiota after colonic cancer surgeryJ H Søby, S K Watt, R P Vogelsang, et al.
European Journal of Endocrinology|November 21, 2024
Response to "Advancing understanding of metabolic consequences of cholecystectomy: review reflection"Andreas H Lange, Miriam G Pedersen, Anne-Marie Ellegaard, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2003
The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotypeT Vilsbøll, F K Knop, T Krarup, et al.
Diabetes, Obesity & Metabolism|February 15, 2013
Reduced postprandial GLP-1 responses in women with gestational diabetes mellitusL Bonde, T Vilsbøll, T Nielsen, et al.
Diabetes, Obesity & Metabolism|February 12, 2017
Effect of exercise combined with glucagon-like peptide-1 receptor agonist treatment on cardiac function: A randomized double-blind placebo-controlled clinical trialPeter G Jørgensen, Magnus T Jensen, Pernille Mensberg, et al.
British Journal of Pharmacology|November 18, 2015
N-terminally and C-terminally truncated forms of glucose-dependent insulinotropic polypeptide are high-affinity competitive antagonists of the human GIP receptorL S Hansen, A H Sparre-Ulrich, M Christensen, et al.
Pageof 51